Psilocybin & Addiction
Days to weeks
Zhao et al. (2024) found psilocybin promoted neuroplasticity in the medial prefrontal cortex via glutamate signaling. Effects appeared within days and persisted for weeks after a single dose. This is the neurobiological basis for why psilocybin's addiction treatment effects outlast the acute experience.
Zhao et al., Journal of Psychopharmacology, 2024
Cell, 2026
highest-impact journal to publish psilocybin cortical rewiring evidence; Jiang et al. showed structural network changes after a single session
Synaptic density
increased in frontal brain regions of pigs after a single psilocybin dose, while 5-HT2A receptor density simultaneously decreased (Raval et al., 2021)
Blunted response
addicted brains show less psilocybin-induced network disruption than healthy brains, with implications for clinical dosing (Reinwald et al., 2023)
Zhao et al., Journal of Psychopharmacology, 2024
View as image ↗In 2021, Raval and colleagues gave a single dose of psilocybin to pigs and measured the result a week later. They chose pigs because pig brains are anatomically and metabolically closer to human brains than rodent brains, with more complex cortical folding, comparable white matter, and similar neurochemistry. What they found: synaptic density had increased in frontal and hippocampal brain regions. Simultaneously, the density of the serotonin receptor that psilocybin activates (5-HT2A) had decreased. The drug was long gone from the pigs' systems. The brain had changed in two directions at once.
That finding captures the central puzzle of psilocybin neuroplasticity research. Psilocybin is active in the body for roughly 4 to 6 hours. The brain changes it produces last weeks. Understanding how that works, and what it means specifically for the addicted brain, is what this article covers. For the clinical outcomes picture, see the psilocybin and alcohol addiction guide.
Key Takeaways
- A single psilocybin dose increased synaptic density in frontal brain regions of pigs while simultaneously decreasing the density of the 5-HT2A receptor it activates, providing direct evidence that psilocybin produces structural brain changes that outlast the drug's presence (Raval et al., Int J Mol Sci, 2021).
- Psilocybin promotes neuroplasticity in the medial prefrontal cortex via glutamate-driven signaling, with effects appearing within days and persisting for weeks after a single dose (Zhao et al., Journal of Psychopharmacology, 2024).
- Addiction produces measurable structural brain damage in the prefrontal cortex. Reduced synaptic density and impaired executive control circuits make quitting physiologically difficult, not just a matter of willpower (Urban et al., Frontiers in Neuroscience, 2023).
- Jiang and colleagues published in Cell (2026) that psilocybin triggers activity-dependent rewiring of large-scale cortical networks, weakening the self-reinforcing recurrent loops that maintain rigid behavioral patterns like addiction.
- Alcohol-dependent rats show significantly less psilocybin-induced network disruption than healthy rats, suggesting the addicted brain has a more protected rigid-circuit architecture that may require modified treatment protocols (Reinwald et al., Translational Psychiatry, 2023).
- Behavioral changes in alcohol use disorder patients were largest in the weeks immediately following psilocybin sessions, consistent with a time-limited plasticity window during which new behavioral patterns are most easily established (Bogenschutz et al., 2015).
What Addiction Does to the Brain's Structure Before Psilocybin Enters the Picture
The most important thing to understand about addiction as a brain disease is that it changes the brain physically. These are not metaphorical changes. Addiction leaves measurable structural marks on brain tissue.
Urban and colleagues published a mechanistically comprehensive review in Frontiers in Neuroscience in 2023 covering the neurobiology of treating substance use disorders with classical psychedelics.[1] One of the review's central framings: psilocybin-induced neuroplasticity specifically reverses the neuronal atrophy that chronic substance use produces.
That atrophy is most severe in the prefrontal cortex, the brain region responsible for planning, impulse control, and the ability to override automatic urges. Chronic substance use reduces the density and complexity of the branching structures on neurons that receive signals from neighboring cells (called dendrites). Synaptic connections become fewer and weaker. The glutamate signaling system that normally allows the prefrontal cortex to suppress craving signals from reward circuits becomes dysregulated. One specific glutamate receptor, mGluR2, loses expression in alcohol dependence. When mGluR2 expression drops in the prefrontal cortex, the brain loses a critical mechanism for sending "stop" signals to the reward system.
The practical result: the addicted brain's capacity for top-down behavioral control weakens not because willpower fails but because the physical substrate of that control has been structurally compromised. This reframes what psilocybin's mechanism is actually doing. The question isn't whether psilocybin motivates people to change. The question is whether it repairs the structural damage that makes change physiologically difficult.
For more on how the craving circuit specifically is disrupted in addiction, see psilocybin and craving reduction: mechanisms of action.
The Pig Brain Study: Synaptic Growth and 5-HT2A Downregulation Happening Simultaneously
Raval and colleagues' 2021 study in International Journal of Molecular Sciences is the most concrete structural evidence for psilocybin-induced neuroplasticity currently available.[2]
The choice of pigs mattered. Pig brains are anatomically and metabolically closer to human brains than rodent brains. They have more complex cortical folding, comparable white matter organization, and neurochemistry that more closely parallels the human system. Findings in pig brains translate more directly to human predictions than rodent data typically do.
The result: a single psilocybin dose increased synaptic density in the frontal cortex and hippocampus. The frontal cortex is the region most damaged by addiction. The hippocampus is central to learning new behavioral responses to old triggers, which is exactly what recovery requires. Both regions showed new synaptic growth.
The simultaneous finding is what distinguishes this study. While new synaptic connections were forming, the density of the 5-HT2A receptor that psilocybin had activated was decreasing. The brain grew new connections and turned down the volume on the receptor that triggered that growth.
This dual effect answers why psilocybin's effects outlast the drug by weeks. The structural changes created by 5-HT2A activation persist after the drug clears. And the receptor is temporarily downregulated, which is part of why psilocybin is not typically addictive and why redosing immediately after a session does not produce the same effects. The drug trains the brain to change and then reduces its own leverage for doing so.
Zhao and colleagues extended this picture in a 2024 paper in Journal of Psychopharmacology, testing psilocybin's neuroplasticity effects specifically in the medial prefrontal cortex of mice.[3] Psilocybin promoted structural changes in this region through glutamate signaling and 5-HT2A receptor activation. The effects were rapid, appearing within days of a single dose, and persisted for weeks. The medial prefrontal cortex is both the region most damaged by addiction and the one most critical for the executive control that recovery demands. A treatment that specifically restores structural integrity in this region is mechanistically aligned with what recovery requires.
For more on how 5-HT2A receptor activation drives these changes at the molecular level, see how 5-HT2A agonism creates the psychedelic experience.
The 2026 Cell Paper: How Psilocybin Rewires Large-Scale Cortical Networks
In 2026, Jiang and colleagues published a paper in Cell, the highest-impact journal in biological science.[4] Their finding: psilocybin triggers what they called activity-dependent rewiring of large-scale cortical networks.
Unpacking that phrase matters. The brain's cortex organizes itself into large-scale networks where specific regions communicate with each other repeatedly and preferentially. Some of these communications form recurrent loops: regions that send signals back and forth in self-reinforcing patterns. In addiction, the circuits connecting substance-associated memories to automatic craving responses become some of the most entrenched of these recurrent loops. A cue (a visual, a smell, a social context) activates the loop, which drives craving, which strengthens the loop further. The pattern reinforces itself.
Jiang's team found that psilocybin weakened these cortico-cortical recurrent connections (the back-and-forth signaling within self-reinforcing cortical loops) while simultaneously strengthening connections from perceptual regions and medial cortical regions toward subcortical targets. In plainer terms: psilocybin quiets the brain's internal self-referential loops and amplifies its responsiveness to direct sensory input from the outside world. The brain temporarily becomes more present and less trapped in its own entrenched patterns.
For addiction, this means the circuits that automatically connect trigger cues to craving responses are weakened. The connection is not erased; memory traces remain. But the automatic force of that connection is reduced. This creates the window during which behavioral intervention can install new responses to old triggers.
This mechanistic picture directly explains the habit-disruption framing. For the deeper application to automatic behavior and habit loops, see psilocybin and habit loops: disrupting automatic behavior.
The Blunted Response: Why the Addicted Brain Is Harder to Rewire
A critical finding complicates the optimistic picture: the brain that most needs psilocybin's neuroplasticity effects may be the one least responsive to them.
Reinwald and colleagues published a 2023 study in Translational Psychiatry that tested psilocybin in alcohol-dependent rats.[5] They measured how much the drug disrupted the default mode network (the brain's self-referential circuit that over-engages during rumination and craving) compared to healthy rats. The result: alcohol-dependent rats showed significantly blunted psilocybin-induced default mode network disruption.
The default mode network is the circuit most active during self-referential thought: thinking about your past, anticipating your future, processing your sense of self. In addiction, this network engages heavily in substance-related rumination, replaying memories of use, anticipating future opportunities to use, reinforcing an identity built around the substance. Quieting this network is one of the proposed mechanisms by which psilocybin interrupts addiction's self-sustaining narrative. But if the addicted brain's default mode network is more resistant to disruption, that mechanism is working against a harder target.
Madsen and colleagues, in a 2021 study in European Neuropsychopharmacology, showed that brain network changes after psilocybin correlate with plasma levels of psilocin (the active form of psilocybin in the blood), following a dose-response relationship.[6] This dose-response finding is meaningful in the context of Reinwald's data: if addicted brains show blunted responses, and if those responses scale with dose, then the blunted response in addiction is not necessarily a ceiling. It may mean addiction treatment requires higher doses, multiple sessions, or modified protocols compared to protocols developed in healthy volunteers.
This finding has received no coverage in consumer health content despite its direct implications for clinical protocol design in addiction treatment.
For how the same default mode network mechanism operates in depression (a condition with significant mechanistic overlap), see psilocybin and default mode network changes in depression.
The Plasticity Window: Why the Weeks After a Session Are the Critical Period
If the structural data from Raval and Zhao are correct (that psilocybin produces neuroplastic changes emerging within days and persisting for weeks), there should be a behavioral correlate during that window. There is.
Bogenschutz and colleagues, in their 2015 proof-of-concept study of psilocybin-assisted therapy for alcohol use disorder, found that reductions in drinking were largest in the weeks immediately following each psilocybin session.[7] The effect was not linear across the study period. It spiked post-session, then gradually returned toward baseline. That pattern is exactly what the biology predicts if a post-acute neuroplasticity window exists.
The window is not solely about structural synaptic changes. A 2025 in vitro study found that both psilocybin and its active metabolite psilocin regulate microglial activation in ways that support neuroplasticity.[8] Microglia are the brain's resident immune cells. In chronic addiction, they become persistently activated and produce inflammatory signals that impair synaptic plasticity, the same plasticity that psilocybin is trying to induce. Psilocybin's ability to modulate microglial activation may reduce this inflammatory resistance, creating a more favorable environment for new synaptic connections to form in the days following a session.
Carhart-Harris and colleagues provided the theoretical framework in a 2014 paper in Frontiers in Human Neuroscience: the entropic brain hypothesis.[9] In this framework, entropy describes the flexibility and randomness of neural activity. Healthy brains maintain a balance between order and flexibility. Addicted brains develop what Carhart-Harris called "low-entropy attractor states": deeply grooved patterns that the brain returns to automatically. Addiction is one of the most deeply entrenched of these attractors, its circuitry reinforced by years of repeated activation.
Psilocybin temporarily increases neural entropy. It introduces enough randomness into the system that the brain can briefly escape the attractor. After the acute effects subside and the brain returns to more organized states, the attractor landscape has changed. The grooves are less deep. Whether new grooves form in their place depends on what happens during the window.
This is why integration therapy scheduled in the days and weeks following a psilocybin session is not an optional supplement to the pharmacology. It is the intervention timed to the mechanism. The window opens. The window closes. What happens during the window determines whether structural and network changes translate into lasting behavioral change.
Lion's mane mushroom provides a parallel but mechanistically distinct route to neuroplasticity through nerve growth factor (NGF) stimulation rather than serotonin receptor activation. For a direct comparison of these two mechanisms, see lion's mane and neuroplasticity: can a mushroom rewire your brain?.
The Bottom Line
Addiction damages the prefrontal cortex structurally, reducing synaptic density and impairing the executive control capacity needed for recovery. Psilocybin appears to reverse this damage through rapid synaptogenesis, glutamate-driven prefrontal cortex restoration, microglial modulation, and large-scale cortical network rewiring. The drug's structural effects persist weeks beyond its pharmacological activity because they are embedded in brain architecture, not in ongoing receptor occupation. An important caveat: alcohol-dependent brains show blunted psilocybin-induced network disruption compared to healthy brains (Reinwald et al., 2023), suggesting standard protocols developed in non-addicted volunteers may be insufficient for addiction treatment. The post-acute plasticity window is the period when behavioral therapy most directly interfaces with the biology.
Frequently Asked Questions
Sources & References
- 1RTHM-01811·Urban, Marvin M et al. (2023). “Mini-review: The neurobiology of treating substance use disorders with classical psychedelics..” Frontiers in neuroscience.Study breakdown →PubMed →↩
- 2RTHM-00714·Raval, Nakul Ravi et al. (2021). “A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain..” International journal of molecular sciences.Study breakdown →PubMed →↩
- 3RTHM-00920·Zhao, Xiangting et al. (2024). “Psilocybin promotes neuroplasticity and induces rapid and sustained antidepressant-like effects in mice..” Journal of psychopharmacology (Oxford.Study breakdown →PubMed →↩
- 4RTHM-02233·Jiang, Quan et al. (2026). “Psilocybin triggers an activity-dependent rewiring of large-scale cortical networks..” Cell.Study breakdown →PubMed →↩
- 5RTHM-01775·Reinwald, Jonathan R et al. (2023). “Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent rats..” Translational psychiatry.Study breakdown →PubMed →↩
- 6RTHM-01400·Madsen, Martin K et al. (2021). “Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience..” European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology.Study breakdown →PubMed →↩
- 7RTHM-00673·Bogenschutz, Michael P et al. (2015). “Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study..” Journal of psychopharmacology (Oxford.Study breakdown →PubMed →↩
- 8. Source details for this reference are not yet available.
- 9RTHM-00579·Carhart-Harris, Robin L et al. (2014). “The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs..” Frontiers in human neuroscience.Study breakdown →PubMed →↩